RainDance Technologies said yesterday that it has appointed Andy Watson as vice president and chief marketing officer. Watson will lead RainDance's global marketing and strategy efforts to grow the current commercial targeted sequencing business and prepare the market for the launch of its digital PCR and single-cell analysis products.
Watson joins RainDance from Life Technologies, where he was most recently vice president of SOLiD sequencing product management. Previously, he led Applied Biosystems' (now part of Life Technologies) capillary electrophoresis sequencing business, including instruments, reagents, and software.
Before joining Applied Biosystems, Watson helped found Quantum Dot (acquired by Invitrogen and now part of Life Technologies), where he held executive technical and business management roles. He also led the development of technologies and software for large-scale DNA analysis at Sequana Therapeutics (acquired by Celera); and the Wellcome Trust Sanger Institute.
Watson holds MEng, MA, and BA degrees from King's College, Cambridge University.